Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC By Ogkologos - May 19, 2026 17 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PLANeT study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Zanubrutinib’s Approval Improves Targeted Treatment for CLL January 27, 2023 Selpercatinib Shows Promise against Lung Cancers with Alterations in RET Gene September 27, 2019 What to Know About Cancer Clinical Trial Matching Programs March 14, 2023 New ESMO Framework to Resolve Uncertainties About the De-intensification of Cancer... May 9, 2022 Load more HOT NEWS Company Gives Cancer Patient a New HVAC System After Treatment and... Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among... Tattoo Ink May Show Up as Suspicious Spots in Lymph Nodes... Young Tulsa Mom Grows Closer To Her Own Mom During Almost...
